CONSTELLATION PHARMACEUTICALS INC Contracts & Agreements
40 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (4)
- Human Resources (10)
- Mergers & Acquisitions (1)
- Real Estate (4)
- Uncategorized (6)
- Agreement and Plan of Merger, dated as of June 2, 2021, by and among Constellation Pharmaceuticals, Inc., MorphoSys AG, and MorphoSys Development Inc (Filed With SEC on June 2, 2021)
- Lease, dated as of November 13, 2020, between the Registrant and ARE-MA Region No. 75, LLC (Filed With SEC on February 24, 2021)
- CONSULTING AGREEMENT (Filed With SEC on August 5, 2020)
- Exhibit A Payments Subject to Section 409A (Filed With SEC on August 5, 2020)
- Underwriting Agreement, June 16, 2020, by and among the Company and J.P. Morgan Securities LLC, Jefferies LLC, Cowen and Company, LLC and RBC Capital Markets, LLC (Filed With SEC on June 17, 2020)
- Description of Securities (Filed With SEC on March 10, 2020)
- Underwriting Agreement, dated December 10, 2019, by and among the Company and J.P. Morgan Securities LLC, Jefferies LLC and Cowen and Company, LLC (Filed With SEC on December 11, 2019)
- Securities Purchase Agreement, dated October 1, 2019, by and among the Company and the other parties thereto (Filed With SEC on October 1, 2019)
- Registration Rights Agreement, dated October 1, 2019, by and among the Company and the other parties thereto (Filed With SEC on October 1, 2019)
- Fifth Amendment to Lease, dated as of June 17, 2019, between the Registrant and ARE-MA Region No. 38, LLC (Filed With SEC on August 7, 2019)
- Loan and Security Agreement, dated as of March 20, 2019, by and among the Registrant, the several banks and other financial institutions or entities from time to time parties... (Filed With SEC on March 21, 2019)
- Fourth Amendment, dated as of September 28, 2018, to Lease Agreement, dated as of February 5, 2010, by and between the Registrant and ARE-MA Region No. 38 LLC (Filed With SEC on November 8, 2018)
- Amended and Restated Letter Agreement, dated June 28, 2018, by and between the Registrant and Adrian Senderowicz (Filed With SEC on August 14, 2018)
- Form of Underwriting Agreement (Filed With SEC on July 9, 2018)
- License and Collaboration Agreement, dated as of January 9, 2012, by and among Genentech, Inc., F. Hoffman-La Roche Ltd. and the Registrant (Filed With SEC on July 9, 2018)
- Specimen Stock Certificate evidencing the shares of common stock (Filed With SEC on June 22, 2018)
- Fifth Amended and Restated Investor Rights Agreement, dated as of March 22, 2018, by and among the Registrant and the other parties thereto, as amended (Filed With SEC on June 22, 2018)
- Amended and Restated 2008 Stock Incentive Plan (Filed With SEC on June 22, 2018)
- Form of Incentive Stock Option Agreement under the Amended and Restated 2008 Stock Incentive Plan (Filed With SEC on June 22, 2018)
- Form of Nonstatutory Stock Option Agreement under the Amended and Restated 2008 Stock Incentive Plan (Filed With SEC on June 22, 2018)
- 2018 Equity Incentive Plan (Filed With SEC on June 22, 2018)
- Form of Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on June 22, 2018)
- 2018 Employee Stock Purchase Plan (Filed With SEC on June 22, 2018)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on June 22, 2018)
- License and Collaboration Agreement, dated as of January 9, 2012, by and among Genentech, Inc., F. Hoffman-La Roche Ltd. and the Registrant (Filed With SEC on June 22, 2018)
- Research, Development and Commercialization Agreement, dated as of July 31, 2012, by and between the Registrant and The Leukemia & Lymphoma Society, as amended (Filed With SEC on June 22, 2018)
- Loan and Security Agreement, dated as of April 26, 2016, by and among the Registrant, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on June 22, 2018)
- Warrant to purchase shares of Series B preferred stock issued on June 28, 2013 by the Registrant to Oxford Finance LLC (Filed With SEC on June 22, 2018)
- Warrant to purchase shares of Series B preferred stock issued on June 28, 2013 by the Registrant to Silicon Valley Bank (Filed With SEC on June 22, 2018)
- Warrant to purchase shares of Series B preferred stock issued on September 30, 2014 by the Registrant to Oxford Finance LLC (Filed With SEC on June 22, 2018)
- Warrant to purchase shares of Series B preferred stock issued on September 30, 2014 by the Registrant to Oxford Finance LLC (Filed With SEC on June 22, 2018)
- Form of Common Stock Purchase Warrant, dated May 24, 2011 (Filed With SEC on June 22, 2018)
- Lease Agreement, dated as of February 5, 2010, by and between the Registrant and ARE-MA Region No. 38 LLC, as amended (Filed With SEC on June 22, 2018)
- Letter Agreement, dated March 13, 2017, by and between the Registrant and Jigar Raythatha (Filed With SEC on June 22, 2018)
- Letter Agreement, dated August 30, 2017, by and between the Registrant and Emma Reeve (Filed With SEC on June 22, 2018)
- Amended and Restated Letter Agreement to be entered into by and between the Registrant and Adrian Senderowicz, M.D (Filed With SEC on June 22, 2018)
- Amended and Restated Change in Control Severance Plan (Filed With SEC on June 22, 2018)
- Consulting Agreement, dated as of May 2, 2017, by and between the Registrant and Oncology Drug Development, LLC (Filed With SEC on June 22, 2018)
- Consulting Agreement, dated as of July 15, 2017, by and between the Registrant and Dr. James Audia (Filed With SEC on June 22, 2018)
- Form of Indemnification Agreement between the Registrant and each of its Executive Officers and Directors (Filed With SEC on June 22, 2018)
